Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 6 studies | 27% ± 5% | |
| epithelial cell | 6 studies | 24% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 82% | 1952.31 | 296 / 359 | 94% | 20.38 | 268 / 286 |
| liver | 100% | 2185.96 | 226 / 226 | 71% | 7.16 | 289 / 406 |
| intestine | 66% | 4088.25 | 641 / 966 | 92% | 23.24 | 484 / 527 |
| lung | 80% | 557.63 | 462 / 578 | 28% | 2.92 | 329 / 1155 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.88 | 1 / 1 |
| spleen | 100% | 1990.80 | 240 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 4% | 7.95 | 12 / 328 | 81% | 17.08 | 144 / 178 |
| esophagus | 24% | 75.06 | 343 / 1445 | 60% | 14.75 | 109 / 183 |
| peripheral blood | 80% | 5813.91 | 745 / 929 | 0% | 0 | 0 / 0 |
| bladder | 24% | 48.33 | 5 / 21 | 37% | 6.65 | 188 / 504 |
| brain | 21% | 68.46 | 564 / 2642 | 25% | 0.45 | 176 / 705 |
| adipose | 43% | 178.98 | 514 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 27% | 74.80 | 46 / 170 | 14% | 0.77 | 66 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 1.04 | 17 / 45 |
| skin | 29% | 996.26 | 521 / 1809 | 8% | 0.47 | 36 / 472 |
| breast | 30% | 102.46 | 138 / 459 | 6% | 0.53 | 63 / 1118 |
| thymus | 16% | 37.95 | 106 / 653 | 14% | 0.21 | 84 / 605 |
| blood vessel | 28% | 89.81 | 369 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 6% | 19.04 | 5 / 89 | 20% | 0.52 | 184 / 901 |
| prostate | 24% | 61.24 | 59 / 245 | 2% | 0.02 | 8 / 502 |
| ovary | 24% | 75.75 | 44 / 180 | 1% | 0.03 | 5 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.34 | 6 / 29 |
| adrenal gland | 13% | 28.58 | 34 / 258 | 6% | 0.32 | 14 / 230 |
| heart | 17% | 40.61 | 149 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.18 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0018958 | Biological process | phenol-containing compound metabolic process |
| GO_0050427 | Biological process | 3'-phosphoadenosine 5'-phosphosulfate metabolic process |
| GO_0009812 | Biological process | flavonoid metabolic process |
| GO_0006805 | Biological process | xenobiotic metabolic process |
| GO_0006068 | Biological process | ethanol catabolic process |
| GO_0051923 | Biological process | sulfation |
| GO_0042403 | Biological process | thyroid hormone metabolic process |
| GO_0006576 | Biological process | biogenic amine metabolic process |
| GO_0030855 | Biological process | epithelial cell differentiation |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008146 | Molecular function | sulfotransferase activity |
| GO_0004062 | Molecular function | aryl sulfotransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SULT1B1 |
| Protein name | Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase) Sulfotransferase (EC 2.8.2.-) |
| Synonyms | ST1B2 SULT1B2 |
| Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of dopamine, small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triidothyronine (T3) and reverse triiodothyronine (rT3) . May play a role in gut microbiota-host metabolic interaction. O-sulfonates 4-ethylphenol (4-EP), a dietary tyrosine-derived metabolite produced by gut bacteria. The product 4-EPS crosses the blood-brain barrier and may negatively regulate oligodendrocyte maturation and myelination, affecting the functional connectivity of different brain regions associated with the limbic system . . |
| Accessions | ENST00000510821.1 D6RIA8 D6RD70 ENST00000310613.8 ENST00000512870.1 O43704 |